Business, energy, technology, markets and global industry news from Business News Today

Systane

Pharma & Biotech

Alcon’s new eye drops last up to 12 hours. Can BRYTLY challenge Lumify?

The FDA has approved BRYTLY, Alcon's 0.125% apraclonidine eye drops, for temporary relief of redness caused by minor irritation in people aged 12 and older. Alcon claims effects within one minute lasting up to 12 hours, although its longer-duration comparison with Lumify is based on product labeling rather than a disclosed head-to-head trial.

Read More
Pharma & Biotech

Can Alcon turn baseball fandom into a growth engine for Systane in Canada’s dry eye category?

See how Alcon is using the Toronto Blue Jays to expand Systane’s dry eye reach in Canada and what it means for eye care competition.

Read More